Further evaluation of the myogenic capacity of these 4 DMD cell populations showed that, in contrast to CD133+ cells derived from skeletal muscle of normal donors, which were all highly myogenic in vitro (Fig. 2), there were large variations in myogenicity amongst the DMD cell preparations. This evidence concerns the gene PROM1 and Duchenne muscular dystrophy.